Page 73 - JCTR-10-1

Zhuang et al. | Journal of Clinical and Translational Research 2024; 10(1): 62-71 69
Funding A Study of 82 Cases Occurring in Patients Younger than
22 Years of Age. Am J Surg Pathol 2009;33:645-58.
This work was supported by the special fund for public welfare
research institutes of Fujian Province, China (2023R1037). doi: 10.1097/PAS.0b013e3181963c9c
[6] Dei TA. Liposarcomas: Diagnostic Pitfalls and New
Conflicts of Interest Insights. Histopathology 2014;64:38-52.
The authors have no conflicts of interest to disclose. doi: 10.1111/his.12311
[7] Abaricia S, Hirbe AC. Diagnosis and Treatment of Myxoid
Author Contributions Liposarcomas: Histology Matters. Curr Treat Options
Aobo Zhuang, Yingxue Cheng, and Yue Wang contributed to Oncol 2018;19:64.
the design of the study. Zhe Xi, Guangting Yan, and Gen Zhang doi: 10.1007/s11864-018-0590-5
contributed to recruiting patients. Jialiang Zheng, Lingwei Gu, [8] Panagopoulos I, Mandahl N, Ron D, Hoglund M, Nilbert M,
and Peng Li contributed to collecting data. Wengang Li, Lanlan Mertens F, et al. Characterization of the CHOP Breakpoints
Lian, Xi Li, Fuan Xie, and Ting Wu approved the final version of and Fusion Transcripts in Myxoid Liposarcomas with the
this manuscript and were responsible for the decision to submit 12;16 Translocation. Cancer Res 1994;54:6500-3.
the manuscript. [9] Knight JC, Renwick PJ, Dal Cin P, Van den Berghe H,
Fletcher CD. Translocation t(12;16)(q13;p11) in Myxoid
Ethics Approval and Consent to Participate
Liposarcoma and Round Cell Liposarcoma: Molecular and
This article does not contain any studies with human or animal Cytogenetic Analysis. Cancer Res 1995;55:24-7.
subjects performed by any of the authors. [10] Fiore M, Grosso F, Lo VS, Pennacchioli E, Stacchiotti S,
Ferrari A, et al. Myxoid/Round Cell and Pleomorphic
Consent for Publication Liposarcomas: Prognostic Factors and Survival in a

Not applicable. Series of Patients Treated at a Single Institution. Cancer
2007;109:2522-31.
Availability of Data doi: 10.1002/cncr.22720

The data that support the findings of this study are available [11] Spillane AJ, Fisher C, Thomas JM. Myxoid
from SEER database. Data are available from the authors on Liposarcoma--the Frequency and the Natural History of
reasonable request and with permission of SEER database. Nonpulmonary Soft Tissue Metastases. Ann Surg Oncol
1999;6:389-94.
References doi: 10.1007/s10434-999-0389-5

[1] Doyle LA. Sarcoma Classification: An Update Based on the [12] Estourgie SH, Nielsen GP, Ott MJ. Metastatic Patterns of
2013 World Health Organization Classification of Tumors Extremity Myxoid Liposarcoma and their Outcome. J Surg
of Soft Tissue and Bone. Cancer 2014;120:1763-1774. Oncol 2002;80:89-93.
doi: 10.1002/cncr.28657 doi: 10.1002/jso.10093
[2] Setsu N, Miyake M, Wakai S, Nakatani F, Kobayashi E, [13] Pitson G, Robinson P, Wilke D, Kandel RA, White L,
Chuman H, et al. Primary Retroperitoneal Myxoid Griffin AM, et al. Radiation Response: An Additional
Liposarcomas. Am J Surg Pathol 2016;40:1286-90. Unique Signature of Myxoid Liposarcoma. Int J Radiat
doi: 10.1097/PAS.0000000000000657 Oncol Biol Phys 2004;60:522-6.
[3] Zhuang A, Zhuang A, Wu Q, Lu W, Tong H, Zhang Y. doi: 10.1016/j.ijrobp.2004.03.009
Prognostic Factor Analysis and Nomogram Construction [14] Vijay A, Ram L. Retroperitoneal Liposarcoma:
of Primary Retroperitoneal Liposarcoma: A Review of 10 A Comprehensive Review. Am J Clin Oncol 2015;38:213-9.
Years of Treatment Experience in a Single Asian Cohort of doi: 10.1097/COC.0b013e31829b5667
211 Cases. Front Oncol 2021;11:777647. [15] Lou Y, Ma Y, Li H, Song Y, Zhang X, Lin H, et al. High
doi: 10.3389/fonc.2021.777647 Expression of Fibroblast Growth Factor-21 in Liposarcoma
[4] Kilpatrick SE, Doyon J, Choong PF, Sim FH, Patients Indicated Better Prognosis and Less Recurrence.
Nascimento AG. The Clinicopathologic Spectrum of Biochem Biophys Res Commun 2018;503:1130-3.
Myxoid and Round Cell Liposarcoma. A Study of 95 doi: 10.1016/j.bbrc.2018.06.130
Cases. Cancer 1996;77:1450-8. [16] Perrone F, Tamborini E, Suardi S, Lagonigro MS, Pilotti S.
doi: 10.1002/(SICI)1097-0142(19960415)77:8<1450::AID- Re: Oda et al. Frequent Alteration of p16INK4a/p14ARF
CNCR5>3.0.CO;2-G and p53 Pathways in the Round Cell Component of
[5] Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Myxoid/Round Cell Liposarcoma: p53 Gene Alterations
Oliveira AM, et al. Liposarcomas in Young Patients: and Reduced p14ARF Expression Both Correlate with
DOI: https://doi.org/10.36922/jctr.00113